Chapters

Transcript

Video

Can you discuss the 12-month data from the CAHtalyst trials reporting on long term results in both adult & pediatric populations with CAH, including persons who were started on crinecerfont as well as those who crossed over to the crinecerfont group?

Can you discuss the 12-month data from the CAHtalyst trials reporting on long term results in both adult & pediatric populations with CAH, including persons who were started on crinecerfont as well as those who crossed over to the crinecerfont group?


Created by

CMEducation Resources | iQ&A Congenital Adrenal Hyperplasia (CAH) Medical Intelligence Zone 

Presenter

Richard Auchus, MD, PhD

Richard Auchus, MD, PhD

Professor of Pharmacology and Internal Medicine
Division of Metabolism, Endocrinology, and Diabetes
University of Michigan School of Medicine
Ann Arbor, Michigan